+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood DNA Kit Market by Test Type, Application, Distribution Channel, Technique, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083387
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood DNA kit market is rapidly evolving as technological advancements, clinical adoption, and consumer demand converge. Senior decision-makers are navigating a landscape where data-driven precision and agile supply chain strategies are key to sustained market leadership.

Market Snapshot: Blood DNA Kit Market Growth

The Blood DNA Kit Market grew from USD 936.38 million in 2024 to USD 997.18 million in 2025 and is forecast to continue at a CAGR of 6.25%, reaching USD 1.34 billion by 2030. This growth reflects rising demand for both clinical and consumer genetic testing solutions, as supply chain and regulatory shifts reshape global dynamics. The market is expanding due to innovations in diagnostics, increased consumer health awareness, and strategic investments across healthcare, technology, and research domains.

Scope & Segmentation of the Blood DNA Kit Market

  • Test Types: Ancestry (autosomal DNA, mtDNA, Y-DNA), Health Risk Assessment (disease predisposition, lifestyle genomics), Paternity, Pharmacogenomics (drug efficacy, drug metabolism)
  • Applications: Ancestry tracking, forensic testing (criminal and paternity investigations), genetic disease screening (carrier, newborn, prenatal screening), personalized medicine (cardiovascular, neurological, oncology)
  • Distribution Channels: Direct enrollment, hospitals and clinics (private and public), online retail (company and e-commerce platforms), pharmacies (hospital and retail)
  • Techniques: Microarray, next generation sequencing (targeted, whole exome, whole genome), polymerase chain reaction (digital, real-time), Sanger sequencing
  • End Users: Diagnostic laboratories (hospital-based, independent), direct-to-consumer (single test or subscription), hospitals, research institutes (academic, biotechnology companies)
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including UK, Germany, France, Russia, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and neighboring countries)
  • Leading Companies Assessed: QIAGEN N.V., Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Promega Corporation, New England Biolabs, Macherey-Nagel, Zymo Research, Takara Bio, PerkinElmer

Key Takeaways for Senior Decision-Makers

  • Dual clinical and consumer demand is driving the evolution of the blood DNA kit market, with integration across diagnostics, wellness, and ancestry.
  • Next generation sequencing and digital PCR technologies are optimizing genetic insight delivery and lowering operational costs for providers.
  • Enhanced data privacy frameworks and transparent consent protocols are building end-user trust as genetic datasets expand in volume and diversity.
  • Strategic partnerships between healthcare systems, biotechnology firms, and tech vendors are enabling product differentiation and regulatory compliance.
  • Investment in local manufacturing and diversified sourcing is creating resilience against supply chain disruptions and regulatory shifts.
  • Direct-to-consumer models, clinical integration, and personalized medicine applications jointly shape growth pathways, catering to both institutional and individual needs.

Tariff Impact on Global Supply Chains

The 2025 US tariffs have noticeably affected blood DNA kit supply chains, prompting realignment of vendor sourcing, procurement strategies, and logistics. Many suppliers are seeking partnerships outside of affected regions and consolidating shipments to control costs. Laboratories and institutions are adjusting procurement contracts to accommodate variable pricing, while accelerating adoption of locally sourced reagents and alternative assay formats. This environment encourages ongoing innovation and proactive inventory management across the sector.

Methodology & Data Sources

This report utilizes a dual approach, combining primary interviews with industry experts and laboratory leaders and secondary research from peer-reviewed literature, regulatory filings, trade reports, and company disclosures. Data triangulation and sensitivity analysis underpin trend validation, ensuring actionable insights relevant to executives.

Why This Report Matters

  • Senior leaders gain a comprehensive understanding of shifting market dynamics, supply chain vulnerabilities, and new technology adoption within the blood DNA kit sector.
  • Strategic recommendations support investment prioritization, product portfolio planning, and risk mitigation in the face of tariff changes and evolving regulatory conditions.
  • Segment-specific insights enable effective resource allocation for market entry, competitive differentiation, and partnership development.

Conclusion

The blood DNA kit market presents a dynamic landscape where technology, regulation, and diversified demand intersect. Leaders who drive innovation, ensure operational flexibility, and embrace collaborative models will be best positioned for sustained value and market relevance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood DNA Kit Market, by Test Type
8.1. Introduction
8.2. Ancestry
8.2.1. Autosomal Dna
8.2.2. Mtdna
8.2.3. Y-Dna
8.3. Health Risk Assessment
8.3.1. Disease Predisposition
8.3.2. Lifestyle Genomics
8.4. Paternity
8.5. Pharmacogenomics
8.5.1. Drug Efficacy
8.5.2. Drug Metabolism
9. Blood DNA Kit Market, by Application
9.1. Introduction
9.2. Ancestry Tracking
9.2.1. Autosomal Dna
9.2.2. Mtdna
9.2.3. Y-Dna
9.3. Forensic Testing
9.3.1. Criminal Investigations
9.3.2. Paternity Investigations
9.4. Genetic Disease Screening
9.4.1. Carrier Screening
9.4.2. Newborn Screening
9.4.3. Prenatal Screening
9.5. Personalized Medicine
9.5.1. Cardiovascular Disorders
9.5.2. Neurological Disorders
9.5.3. Oncology
10. Blood DNA Kit Market, by Distribution Channel
10.1. Introduction
10.2. Direct Enrollment
10.2.1. Clinical Institutions
10.2.2. Corporate Wellness Programs
10.3. Hospitals & Clinics
10.3.1. Private Hospitals
10.3.2. Public Clinics
10.4. Online Retail
10.4.1. Company Websites
10.4.2. E-Commerce Platforms
10.5. Pharmacies
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
11. Blood DNA Kit Market, by Technique
11.1. Introduction
11.2. Microarray
11.3. Next Generation Sequencing
11.3.1. Targeted Sequencing
11.3.2. Whole Exome Sequencing
11.3.3. Whole Genome Sequencing
11.4. Polymerase Chain Reaction
11.4.1. Digital Pcr
11.4.2. Real-Time Pcr
11.5. Sanger Sequencing
12. Blood DNA Kit Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.2.1. Hospital Based Labs
12.2.2. Independent Labs
12.3. Direct-To-Consumer
12.3.1. Single Test Purchase
12.3.2. Subscription Services
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
12.5. Research Institutes
12.5.1. Academic Institutions
12.5.2. Biotechnology Companies
13. Americas Blood DNA Kit Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Blood DNA Kit Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Blood DNA Kit Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. QIAGEN N.V.
16.3.2. Thermo Fisher Scientific, Inc.
16.3.3. Merck KGaA
16.3.4. Bio-Rad Laboratories, Inc.
16.3.5. Promega Corporation
16.3.6. New England Biolabs, Inc.
16.3.7. Macherey-Nagel GmbH & Co. KG
16.3.8. Zymo Research Corp.
16.3.9. Takara Bio, Inc.
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BLOOD DNA KIT MARKET MULTI-CURRENCY
FIGURE 2. BLOOD DNA KIT MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD DNA KIT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BLOOD DNA KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BLOOD DNA KIT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD DNA KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISEASE PREDISPOSITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD DNA KIT MARKET SIZE, BY LIFESTYLE GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG EFFICACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG METABOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CRIMINAL INVESTIGATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY INVESTIGATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CLINICAL INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CORPORATE WELLNESS PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD DNA KIT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BLOOD DNA KIT MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SINGLE TEST PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SUBSCRIPTION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BLOOD DNA KIT MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 133. CANADA BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. CANADA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 135. CANADA BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 136. CANADA BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 137. CANADA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. CANADA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 139. CANADA BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 140. CANADA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 141. CANADA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 142. CANADA BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. CANADA BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 144. CANADA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 145. CANADA BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 146. CANADA BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 147. CANADA BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 148. CANADA BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 149. CANADA BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 150. CANADA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. CANADA BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 152. CANADA BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 153. CANADA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. CANADA BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. MEXICO BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 161. MEXICO BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 162. MEXICO BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 163. MEXICO BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 164. MEXICO BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. MEXICO BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 166. MEXICO BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 168. MEXICO BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 170. MEXICO BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 171. MEXICO BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 172. MEXICO BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. MEXICO BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 174. MEXICO BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 175. MEXICO BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 210. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 211. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 212. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 213. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 214. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 215. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 216. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 218. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 219. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 252. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 260. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 264. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 266. GERMANY BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 267. GERMANY BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 268. GERMANY BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 269. GERMANY BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 270. GERMANY BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. GERMANY BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 272. GERMANY BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 273. GERMANY BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 274. GERMANY BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 275. GERMANY BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. GERMANY BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 277. GERMANY BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 278. GERMANY BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 279. GERMANY BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 280. GERMANY BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 281. GERMANY BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 282. GERMANY BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 283. GERMANY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. GERMANY BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 285. GERMANY BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 286. GERMANY BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. GERMANY BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 288. FRANCE BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 289. FRANCE BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 290. FRANCE BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 291. FRANCE BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 292. FRANCE BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. FRANCE BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 294. FRANCE BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 295. FRANCE BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 296. FRANCE BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 297. FRANCE BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. FRANCE BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 299. FRANCE BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 300. FRANCE BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 301. FRANCE BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. FRANCE BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 303. FRANCE BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 304. FRANCE BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 305. FRANCE BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. FRANCE BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 307. FRANCE BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 308. FRANCE BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 309. FRANCE BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 310. RUSSIA BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 311. RUSSIA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 312. RUSSIA BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 313. RUSSIA BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 314. RUSSIA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. RUSSIA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 316. RUSSIA BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 317. RUSSIA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 318. RUSSIA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 319. RUSSIA BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. RUSSIA BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 321. RUSSIA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 322. RUSSIA BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 323. RUSSIA BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 324. RUSSIA BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 325. RUSSIA BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 326. RUSSIA BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 327. RUSSIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. RUSSIA BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 329. RUSSIA BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2030 (USD MILLION)
TABLE 330. RUSSIA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. RUSSIA BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 332. ITALY BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 333. ITALY BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2030 (USD MILLION)
TABLE 334. ITALY BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 335. ITALY BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 336. ITALY BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. ITALY BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2030 (USD MILLION)
TABLE 338. ITALY BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 339. ITALY BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 340. ITALY BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 341. ITALY BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. ITALY BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2030 (USD MILLION)
TABLE 343. ITALY BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 344. ITALY BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 345. ITALY BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 346. ITALY BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 347. ITALY BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood DNA Kit market report include:
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • New England Biolabs, Inc.
  • Macherey-Nagel GmbH & Co. KG
  • Zymo Research Corp.
  • Takara Bio, Inc.
  • PerkinElmer, Inc.

Table Information